We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
Updated: 3/11/2016
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
Updated: 3/11/2016
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
Updated: 3/14/2016
Bilicurves: Using Information Technology to Integrate Clinical Practice Guidelines Into the Management of Neonatal Hyperbilirubinemia
Status: Enrolling
Updated: 3/14/2016
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
Updated: 3/14/2016
Bilicurves: Using Information Technology to Integrate Clinical Practice Guidelines Into the Management of Neonatal Hyperbilirubinemia
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Pentoxifylline Treatment of Acute Pancreatitis
Updated: 3/14/2016
Pentoxifylline Treatment in Acute Pancreatitis; A Double-Blind Placebo-Controlled Randomized Trial
Status: Enrolling
Updated: 3/14/2016
Pentoxifylline Treatment of Acute Pancreatitis
Updated: 3/14/2016
Pentoxifylline Treatment in Acute Pancreatitis; A Double-Blind Placebo-Controlled Randomized Trial
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Rebound Hernia Repair Device Mesh Trial
Updated: 3/14/2016
Rebound Hernia Repair Device Trial
Status: Enrolling
Updated: 3/14/2016
Rebound Hernia Repair Device Mesh Trial
Updated: 3/14/2016
Rebound Hernia Repair Device Trial
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Rebound Hernia Repair Device Mesh Trial
Updated: 3/14/2016
Rebound Hernia Repair Device Trial
Status: Enrolling
Updated: 3/14/2016
Rebound Hernia Repair Device Mesh Trial
Updated: 3/14/2016
Rebound Hernia Repair Device Trial
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
Updated: 3/14/2016
A Multi-center Randomized Controlled Clinical Trial Evaluating Two Application Regimens of Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers.
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose
Updated: 3/14/2016
A Phase 1, Open-label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of [14C]-SHP626 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated: 3/14/2016
A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose
Updated: 3/14/2016
A Phase 1, Open-label Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of [14C]-SHP626 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
A Trial of Esophageal and Gastric Stenting for Leak or Perforation
Updated: 3/15/2016
A Phase II Trial of Esophageal and Gastric Stenting for Leak or Perforation
Status: Enrolling
Updated: 3/15/2016
A Trial of Esophageal and Gastric Stenting for Leak or Perforation
Updated: 3/15/2016
A Phase II Trial of Esophageal and Gastric Stenting for Leak or Perforation
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults
Updated: 3/15/2016
A Pivotal Study of the Use of Nitric Oxide / Plasma Therapy as Produced by the APT001 Plasma / Nitric Oxide Generator in Adult Subjects With a Diabetic Foot Ulcer
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
Updated: 3/15/2016
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
Status: Enrolling
Updated: 3/15/2016
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
Updated: 3/15/2016
hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
Status: Enrolling
Updated: 3/15/2016
Click here to add this to my saved trials
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
Updated: 3/17/2016
A Phase 1 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
Status: Enrolling
Updated: 3/17/2016
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
Updated: 3/17/2016
A Phase 1 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215
Status: Enrolling
Updated: 3/17/2016
Click here to add this to my saved trials
Phase II Study of Irinotecan and Panitumumab
Updated: 3/18/2016
Phase II Study of Irinotecan and Panitumumab as Second-Line Therapy for Patients With Advanced Esophageal Adenocarcinoma
Status: Enrolling
Updated: 3/18/2016
Phase II Study of Irinotecan and Panitumumab
Updated: 3/18/2016
Phase II Study of Irinotecan and Panitumumab as Second-Line Therapy for Patients With Advanced Esophageal Adenocarcinoma
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
Updated: 3/18/2016
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
Updated: 3/21/2016
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
Status: Enrolling
Updated: 3/21/2016
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
Updated: 3/21/2016
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
Updated: 3/21/2016
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
Status: Enrolling
Updated: 3/21/2016
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
Updated: 3/21/2016
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
Status: Enrolling
Updated: 3/21/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix
Updated: 3/23/2016
A Multi-Center, Prospective, Randomized Study With PriMatrix Dermal Repair Scaffold Moist Wound Therapy and Standard of Care Moist Wound Therapy for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/23/2016
Click here to add this to my saved trials
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
Updated: 3/25/2016
A Prospective, Randomized, Open-Label Trial Investigating the Effect of 1 Alpha Hydroxy Vitamin D2 on the Development of Coronary Calcification in New ESRD Patients Using the 1-84/7-84 PTH Ratio to Determine Dosing
Status: Enrolling
Updated: 3/25/2016
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
Updated: 3/25/2016
A Prospective, Randomized, Open-Label Trial Investigating the Effect of 1 Alpha Hydroxy Vitamin D2 on the Development of Coronary Calcification in New ESRD Patients Using the 1-84/7-84 PTH Ratio to Determine Dosing
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
Updated: 3/25/2016
A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer
Status: Enrolling
Updated: 3/25/2016
Click here to add this to my saved trials